Prosecution Insights
Prosecution Insights
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (71%) |
| §102 only | 1 (14%) |
| §112 only | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BORTOLI, JONATHAN | 1 | 76.6% | +38.7% |
| GIAMMONA, FRANCESCA FILIPPA | 1 | 35.7% | +53.3% |
| BRISTOL, LYNN ANNE | 1 | 63.7% | +39.7% |
| ZHANG, KAIJIANG | 1 | 76.5% | +35.3% |
| LAFAVE, ELIZABETH ROSE | 1 | 55.3% | +56.3% |
| FLINDERS, JEREMY C | 1 | 64.3% | +15.5% |
| HANDY, DWAYNE K | 1 | 62.7% | +25.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18056648 | CYTOKINE VARIANT ANTIBODIES AND METHODS OF USE | BRISTOL, LYNN ANNE | 113d overdue |
| 17715890 | LIBRARIES FOR MUTATIONAL ANALYSIS | FLINDERS, JEREMY C | 85d overdue |
| 17721680 | BARCODE-BASED NUCLEIC ACID SEQUENCE ASSEMBLY | LAFAVE, ELIZABETH ROSE | 49d overdue |
| 18319405 | METHODS AND DEVICES FOR DE NOVO OLIGONUCLEIC ACID ASSEMBLY | BORTOLI, JONATHAN | 38d overdue |
| 17368697 | DEVICES AND METHODS FOR LIGHT-DIRECTED POLYMER SYNTHESIS | HANDY, DWAYNE K | 35d overdue |
| 18066953 | COMPOSITIONS AND METHODS FOR DETECTION OF VARIANTS | GIAMMONA, FRANCESCA FILIPPA | 7d |
| 17825863 | METHODS FOR SEAMLESS NUCLEIC ACID ASSEMBLY | ZHANG, KAIJIANG | 13d |
| Art Unit | Apps |
|---|---|
| 1684 | 3 |
| 1797 | 1 |
| 1681 | 1 |
| 1643 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18319405 | METHODS AND DEVICES FOR DE NOVO OLIGONUCLEIC ACID ASSEMBLY | BORTOLI, JONATHAN | 1797 | §103 | Non-Final OA | 38d overdue | Pending | May 17, 2023 |
| 18066953 | COMPOSITIONS AND METHODS FOR DETECTION OF VARIANTS | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Non-Final OA | 7d | Pending | Dec 15, 2022 |
| 18056648 | CYTOKINE VARIANT ANTIBODIES AND METHODS OF USE | BRISTOL, LYNN ANNE | 1643 | §112 | Non-Final OA | 113d overdue | Pending | Nov 17, 2022 |
| 17825863 | METHODS FOR SEAMLESS NUCLEIC ACID ASSEMBLY | ZHANG, KAIJIANG | 1684 | §103 | Non-Final OA | 13d | Pending | May 26, 2022 |
| 17721680 | BARCODE-BASED NUCLEIC ACID SEQUENCE ASSEMBLY | LAFAVE, ELIZABETH ROSE | 1684 | §102 | Final Rejection | 49d overdue | Pending | Apr 15, 2022 |
| 17715890 | LIBRARIES FOR MUTATIONAL ANALYSIS | FLINDERS, JEREMY C | 1684 | §103 | Non-Final OA | 85d overdue | Pending | Apr 07, 2022 |
| 17368697 | DEVICES AND METHODS FOR LIGHT-DIRECTED POLYMER SYNTHESIS | HANDY, DWAYNE K | 1798 | §103 | Final Rejection | 35d overdue | Pending | Jul 06, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial